A primary fish gill cell culture model to assess pharmaceutical uptake and efflux: Evidence for passive and facilitated transport  by Stott, Lucy C. et al.
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The  gill is the  principle  site  of xenobiotic  transfer  to  and  from  the  aqueous  environment.  To replace,
reﬁne  or  reduce  (3Rs)  the  large numbers  of ﬁsh  used  in  in  vivo  uptake  studies  an  effective  in  vitro  screen
is  required  that  mimics  the  function  of  the  teleost  gill.  This  study  uses  a rainbow  trout (Oncorhynchus
mykiss)  primary  gill cell  culture  system  grown  on permeable  inserts,  which  tolerates  apical  freshwa-
ter  thus  mimicking  the intact  organ,  to assess  the  uptake  and  efﬂux  of pharmaceuticals  across  the  gill.
Bidirectional  transport  studies  in  media  of seven  pharmaceuticals  (propranolol,  metoprolol,  atenolol,
formoterol,  terbutaline,  ranitidine  and  imipramine)  showed  they  were  transported  transcellularly  across
the epithelium.  However,  studies  conducted  in water  showed  enhanced  uptake  of propranolol,  ranitidine
and  imipramine.  Concentration-equilibrated  conditions  without  a  concentration  gradient  suggested  that
a proportion  of  the  uptake  of propranolol  and  imipramine  is  via  a carrier-mediated  process.  Further  study
using propranolol  showed  that its transport  is pH-dependent  and  at very  low  environmentally  relevant
−1ainbow trout concentrations  (ng  L ),  transport  deviated  from  linearity.  At  higher  concentrations,  passive  uptake  dom-
inated.  Known  inhibitors  of drug  transport  proteins;  cimetidine,  MK571,  cyclosporine  A  and  quinidine
inhibited  propranolol  uptake,  whilst  amantadine  and  verapamil  were  without  effect.  Together  this  sug-
gests  the involvement  of  speciﬁc  members  of  SLC  and  ABC  drug  transporter  families  in  pharmaceutical
transport.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
There are currently over 140,000 compounds that are being
eassessed for their bioconcentrative properties as a part of the
U Registration, Evaluation, Authorization & Restriction of Chem-
cals (REACH) initiative (REACH, 2009). Conventionally, the main
eterminant used for assessing bioconcentration of a compound
s the octanol–water partitioning coefﬁcient (Kow), a measure of
Abbreviations: 3Rs, reduce, reﬁne, replace; A, apical; ABC, ATP-binding cas-
ette; B, basal; BCF, bioconcentration factor; BTA, bi-directional transport assay;
ETA, concentration equilibrated transport assay; Ci, Curie; Dpm, disintegrations
er minute; Kow, octanol–water partitioning coefﬁcient; MRP, multidrug resis-
ance protein; OCT, organic cation transporter; OECD, Organisation for Economic
o-operation and Development; Papp, apparent permeability coefﬁcient; pKa, dis-
ociation constant; QSARs, quantitative structure–activity relationships; REACH,
egistration, Evaluation, Authorization & Restriction of Chemicals; SLC, solute car-
ier; TER, transepithelial resistance; TEP, transepithelial potential; TR, transport
atio.
∗ Corresponding author. Tel.: +44 2078484091; fax: +44 2078484500.
E-mail address: Nic.Bury@kcl.ac.uk (N.R. Bury).
ttp://dx.doi.org/10.1016/j.aquatox.2014.12.007
166-445X/© 2014 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
hydrophobicity that drives sorption and accumulation, and a main
input parameter in quantitative structure–activity relationships
(QSARs) (Hansch, 1969). However, this may  not be fully applica-
ble to pharmaceuticals, many of which are polar and ionizable
(Hermens et al., 2013). In this case, the pH-corrected octanol–water
partitioning coefﬁcient, Dow, may  be used, but this fails to take into
account other major interactions such as hydrogen bonding and van
der Waals forces, as well as uptake via carrier-mediated processes
(Dobson and Kell, 2008; Sugano et al., 2010).
In vivo ecotoxicology testing produces bioconcentration factor
(BCF) values that indicate the potential of a compound to biocon-
centrate within an organism (OECD305, 2012). Fish are exposed to
highly lipophilic compounds via the diet, whilst to others via the
water; the principle being to use the uptake and depuration rates
to calculate the propensity of a compound to bioconcentrate. Typ-
ically, each test can use up to 108 ﬁsh per compound and many
thousands of ﬁsh are used for this test every year (Scholz et al.,
2013). There is currently a desire to develop alternative methods to
replace these standardized whole ﬁsh studies to recognize and clas-
sify environmental hazards (Creton et al., 2013; Wolf et al., 2007).
This requires the identiﬁcation and validation of appropriate in vitro
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ystems that could replace such studies (Baron et al., 2012; Uchea
t al., 2013). To ﬁnd alternatives to the OECD305 water exposure it
s necessary to identify a suitable ﬁsh gill model that mimics the
ntact organ because the gill, being constantly and continuously
xposed to substances in water, is the principle site of xenobiotic
ptake (Bury et al., 2014).
Fletcher et al. (2000) developed a double-seeding technique that
nables primary gill cells to be cultured on permeable membrane
nserts in a two-compartment model. This cultured epithelium
omprises the different cell types (mitochondrial rich cells, respi-
atory cells and mucus cells) found in the gill and produces
igh transepithelial resistance (reviewed by Bury et al., 2014).
mportantly, the system is able to tolerate apical freshwater and
roduces a negative transepithelial potential, further simulating
he in vivo scenario. This is crucial when investigating the transport
f ionizable compounds such as pharmaceuticals that may  behave
ifferently in culture medium and water. Furthermore, the gill cells
rom two ﬁsh can be used to create up to 72 individual gill epithe-
ial inserts for assaying, thus potentially reducing numbers of ﬁsh
n in vivo testing.
The present study thus aims to use the in vitro gill to investi-
ate the uptake and efﬂux of seven pharmaceuticals representing
 range of classes. We  hypothesize that both passive transcellu-
ar and carrier-mediated transport of xenobiotics across the gill
re likely principle drivers in determining the rate of uptake of
aterborne compounds (Mckim and Erickson, 1991). Passive tran-
cellular transport depends on the pH of the solution, acid–base
onstants (pKa) and the lipophilicity of the compound, whereas
acilitated transport may  be via members of the solute carrier (SLC)
nd ATP-binding casette (ABC) transporter families (Dobson and
ell, 2008). Therefore, to investigate carrier-mediated transport
or some of these pharmaceuticals, concentration-equilibrated,
H-dependent, and concentration-dependent assays, as well as
embrane channel inhibitor studies were conducted. In the con-
ext of this work, paracellular transport refers to the movement
f compounds over membranes between cells and passive trans-
ort refers to concentration-dependent transcellular processes,
hereas facilitated transport indicates concentration-independent
arrier-mediated transport via membrane channel proteins. In
ddition, the uptake of propranolol across the in vitro gill model was
ompared to in silico and in vivo data (Owen et al., 2009), to demon-
trate the use of this model as a predictive tool for pharmaceutical
ptake.
. Materials and methods
.1. Animal husbandry
Gill cells for the use in primary cultures were obtained from
uvenile diploid rainbow trout weighing 50–120 g purchased
rom a trout farm (Hampshire, UK). Fish were acclimatized in
hree 1000 L ﬁberglass aquaria at King’s College, London, and
aintained at 13–14 ◦C in recirculating aerated city of London
ap water ([Na+] = 0.53 mM,  [Ca2+] = 0.92 mM,  [Mg2+] = 0.14 mM,
K+] = 0.066 mM and [NH4+] = 0.027 mM),  which was passed
hrough carbon, mechanical and biological ﬁlters. Photoperiod was
aintained at a constant 14 h light/10 h dark cycle and ﬁsh were
ed a daily 1% (w/w) ration of ﬁsh chow.
.2. Gill cell cultureSterile techniques were used throughout all cell culture pro-
edures. Equipment, containers and solutions were autoclaved or
terile ﬁltered (0.2 m,  Corning). The gill cell isolation procedure
as based on methods previously documented (Fletcher et al.,ogy 159 (2015) 127–137
2000) and the cell culture double-seeded insert (DSI) technique as
described by Walker et al. (2008) and Wood et al. (2002). Brieﬂy,
primary gill cells are isolated, washed and resuspended in L-15
medium (Invitrogen) supplemented with FBS (5% (v/v)) (Sigma)
and seeded onto a permeable polyethylene terephthalate (PET)
membrane inserts with 0.4 m pores with an area of 0.9 cm2 and
maintained at 18 ◦C. This Transwell system (Corning) has an apical
compartment above and a basal compartment below.
The development of an intact and electrically tight gill epithe-
lium was monitored daily through ‘blank’-corrected measurements
of transepithelial resistance (TER) using a custom-modiﬁed epithe-
lial tissue voltohmeter (EVOMX; World Precision Instruments)
ﬁtted with chopstick electrodes (STX-2). The same device was used
to measure transepithelial potential (TEP) before and after freshwa-
ter application. DSI epithelia that reached a TER of ≥5 k cm2 were
considered developed and electrically ‘tight’ for experimental pro-
cedures. In this instance, DSI preparations were washed twice with
PBS (to remove any media supplemented with FBS) and exposed
to radiolabeled pharmaceuticals apically in either L-15 medium
(without FBS) or freshwater (2.0 mM CaCl2, 0.5 mM MgSO4, 0.8 mM
NaHCO3, 77.1 M KCl at pH 7.7), or basally, always in L-15
medium. L-15 medium has an osmolarity of 300–320 mOsm kg−1
(Invitrogen) and that of freshwater is around 15 mOsm kg−1. All
experiments and exposures are based on individual inserts (n)
derived from at least one biological replicate. Due to the seeding
procedure over two  days, one biological replicate is derived from
two ﬁsh.
2.3. Membrane permeability
Paracellular permeability was measured using the paracellu-
lar marker 14C-mannitol (20 Ci mmol−1, Amersham Biosciences,
CAS no. 88404-24-4). Thirty-seven DSI epithelia with TER val-
ues ranging from 0 to 14 k cm2 were exposed to 0.013 Ci
(2.2 × 105 dpm) 14C-mannitol in 1.5 mL  sterile freshwater in the
apical compartment, with 2.0 mL  L-15 medium in the basal
(Hubatsch et al., 2007). From this, a TER value at which paracellular
transport is at its most minimal can be deduced as a threshold for
when epithelia are ready for transport assays (≥5 k cm2). Aliquots
of 100 L were taken from the apical and basal compartments at
time 0 and 24 h, and placed in 2 mL liquid scintillation ﬂuid (Ecol-
ume) and radioactivity measured by beta counting (Tri Carb 460CD
liquid scintillation system; Packard). Mannitol ﬂux after 24 h was
calculated using Eq. (1):
Permeability (cm s−1) = [M]BL × volume
MAP × time × 3600 × area
(1)
where [M]BL is the change in radioactivity in the basal compart-
ment, MAP is the radioactivity at the start, time is 24 h and area is
0.9 cm2 (Fletcher et al., 2000).
2.4. Radiolabeled pharmaceuticals
All drugs used in transport assays were at a concentration
of 1 g L−1 to represent the levels detected in the environment
whilst remaining within detectable limits (Table 1). These were
purchased radiolabeled and re-suspended in ethanol or methanol
with a ﬁnal solvent concentration in assay conditions of <0.0003%,
and chosen to demonstrate a range of different classes (1-,
2- and non-speciﬁc -receptor agonists, a H2-receptor agonist
and a tricyclic anti-depressant) with mid-range log Kow values
(see Table 1). This method of using labeled compounds allows
for the recovery of label during cell-free conditions to calculate
the amount that sticks to plastic ware. Furthermore, the label
may  be detected as either the parent compound or biotrans-
formed products. 3H-propranolol hydrochloride (29.0 Ci mmol−1,
L.C. Stott et al. / Aquatic Toxicology 159 (2015) 127–137 129
Table  1
Properties of selected pharmaceuticals and the levels at which they are found in the environment.
Pharmaceutical Use MW pKa log Kow1 log Kow2 Environmental levels (ng L−1)
Propranolol Non-selective  antagonist 259.340 9.4 2.54 1.12* 333
Metoprolol 1 receptor antagonist 267.364 9.6 1.76 –0.90# 4103
Atenolol 1 receptor antagonist 266.336 9.6 0.67 0.0015* 9403
Formoterol Long-acting 2 agonist 344.405 7.9a/9.2b 1.93 0.41* n/a
Terbutaline 2-Adrenergic receptor agonist 225.284 8.86a/9.76b 1.25 1.29 74
Ranitidine H2-receptor antagonist 314.4 8.08 1.47 1203
Imipramine Tricyclic antidepressant 280.407 9.4 4.39 0.145
1 Parameter Client (Tetko et al., 2005).
2 Environmental Risk Assessment data, experimentally measured values (AstraZeneca, 2014).
3 Kostich et al. (2014).
4 Breitholtz et al. (2012).
5 Giebułtowicz and Nałe˛cz-Jawecki (2014).
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AS no. 152588-63-93) was obtained from Amersham Biosciences.
H-metoprolol (29.7 Ci mmol−1), 3H-formoterol (18.5 Ci mmol−1)
nd 3H-terbutaline (29.0 Ci mmol−1) were obtained from Vit-
ax. 3H-Atenolol (7.3 Ci mmol−1) and 3H-ranitidine (2.5 Ci mmol−1)
ere obtained from Moravek Biochemicals, and 3H-imipramine
ydrochloride (48.5 Ci mmol−1, CAS no. 113-52-0) from Perkin-
lmer.
.5. Bidirectional transport assays and apparent permeability
oefﬁcients
Bidirectional transport assays (BTA) assess both passive and
acilitated transport in a bidirectional manner, from apical to basal
uptake) or vice versa (efﬂux). In these, concentration gradient con-
itions exist, whereby total transport is a sum of both passive
ranscellular and carrier-mediated processes. DSI epithelia with a
ER > 5 k cm2 with low paracellular transport rates were exposed
o test compounds in either symmetrical or asymmetrical condi-
ions. Symmetrical contained 1.5 and 2.0 mL  L-15 (without FBS) in
pical and basal compartments respectively, whilst asymmetrical
equired the application of 1.5 mL  freshwater in the apical compart-
ent and 2.0 mL  L-15 in the basal. The test compound was  added to
ither the apical side (uptake; A:B) or basal compartment (efﬂux;
:A) at a concentration of 1 g L−1. Each experimental condition
sed 3–5 epithelial inserts from 1 to 2 biological replicates. For all
xperiments the water or media from the apical or basal compart-
ent was mixed before taking 100 L samples at 0, 6, 24, 30 and
8 h. Each 100 L aliquot sample was placed into scintillation vials
ith scintillation ﬂuid and beta-counted, and the drug concentra-
ion was calculated from the speciﬁc radioactivities. For uptake and
fﬂux BTA, apparent permeability coefﬁcients (Papp) at 6 h were
alculated using Eq. (2):
app(cm s−1) = (dQ/dt  × 1/(A × C0))3600 (2)
here dQ/dt is the ﬂux rate of the drug (pmol L−1 h−1), A is the
urface area of the monolayer (0.9 cm2) and C0 is the initial con-
entration of the drug in the donor compartment (fM) (Petri et al.,
004). Transport ratios (TR) for both uptake and efﬂux were calcu-
ated using Eqs. (3) and (4) (Schwab et al., 2003).
ptake TR = Papp A:B
Papp B:A
(3)
P
fﬂux TR = app B:A
PappA:B
(4)
An uptake or efﬂux TR ≥ 1.5 is considered an indicator of active
ransport (Schwab et al., 2003; Luna-Tortós et al., 2008). Fortime-dependent BTA, the results were also expressed as the per-
centage of the initial drug concentration of the donor compartment
for uptake (A:B) and efﬂux (B:A) over 48 h.
2.6. Concentration equilibrium transport assays
Concentration equilibrium transport assays (CETA) examine
transport by adding equivalent concentrations on either side
of the gill epithelium and assessing the movement of com-
pounds over time to evaluate carrier-mediated uptake or efﬂux
regardless of passive transport processes, as used in blood–brain
barrier transport assays (Luna-Tortós et al., 2008). The same
experimental procedures for BTA were used (in symmetrical and
asymmetrical conditions), but with both apical and basal com-
partments containing test drugs at the same concentration of
1 g L−1. The results are expressed as a percentage of the ini-
tial concentration in each compartment (apical or basal) over
time.
2.7. The pH-dependent transport of propranolol
DSI epithelia were exposed in apical freshwater adjusted to pH
6 (by addition of HCl), pH 8 or pH 9.5 (by addition of NaOH; Corning
pH meter 140). Radiolabeled propranolol was  added at a concentra-
tion of 1 g L−1 to either the apical or basal compartments (BTA) to
investigate uptake and efﬂux. At 6 h a 100 L sample was collected
from the apical and basal compartments and radioactivity analyzed
as above, and apparent permeability coefﬁcients (Papp) calculated
using Eq. (2).
2.8. The concentration-dependent uptake of propranolol
DSI epithelia (n = 54) were exposed to 17 concentrations of
propranolol ranging from 0.014 to 10,000 g L−1. Concentrations
above 0.1 g L−1 were made using propranolol hydrochloride
(Sigma, CAS no. 318-98-9) and radiolabeled propranolol as a
marker. Experiments were conducted in asymmetrical conditions
with propranolol added to the water in the apical compart-
ment, thus mimicking the in vivo scenario (Owen et al., 2009).
Radioactivity was  analyzed as previously described in Section
2.3.
2.9. The inhibition of the uptake of propranololCells were pre-incubated with inhibitor at a concentration
100 times higher (400 nM)  than that of propranolol to competi-
tively inhibit the membrane channel. Amantadine (Sigma, CAS no.
1 oxicology 159 (2015) 127–137
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Fig. 1. The relationship between 14C-mannitol permeability (after 24 h) and
transepithelial electrical resistance (TER) in 37 cultured rainbow trout gill epithelia30 L.C. Stott et al. / Aquatic T
68-94-5), cimetidine (ICN, CAS no. 51481-61-9), cyclosporine A
Fluka, CAS no. 59865-13-3), MK571 (Tocris Biosciences, CAS no.
15104-28-4), quinidine (Sigma, CAS no. 56-54-2) or verapamil
ydrochloride (Fluka, CAS no. 152-11-4) were dissolved in DMSO
0.1% in ﬁnal solution) and added to the apical (in 0.75 mL  freshwa-
er) or basal (in 1.0 mL  L-15 medium). Controls and compartments
ithout inhibitor contained 0.1% DMSO. After 1 h, volumes were
eplaced with 1.5 mL  freshwater containing 1 g L−1 (4 nM)  pro-
ranolol apically and 2.0 mL  L-15 basally, whilst keeping the ﬁnal
oncentration of inhibitor at 400 nM throughout. The same samp-
ing procedure as for BTA at time 0, 6 (not for cyclosporine A), 24,
6 and 48 h proceeded and the uptake Papp of propranolol was  cal-
ulated using Eq. (2). The Papp in all inhibitor-free controls were
xpressed as a percentage of the mean (100%) and the change in
ptake Papp (inhibition) in the presence of inhibitors was  expressed
s a percentage of this mean control.
.10. Analysis of data and statistics
For bidirectional Papp comparisons between the uptake and
fﬂux, an independent samples t-test with equal variances assumed
as used and statistical signiﬁcance was accepted when P < 0.05
SPSS software, SPSS Inc.). The same statistical analysis was used
o test for differences between asymmetrical and symmetrical
ptake or efﬂux Papp for each drug to assess the effect of apical
reshwater application. For the time-dependent BTA signiﬁcant dif-
erences between the uptake and efﬂux percentage of the donor
ompartment were tested for by one-way analysis of variance
ANOVA) on log-transformed data (SPSS software, SPSS Inc.). For
he time-dependent CETA the statistical signiﬁcance of differences
etween each percentage increase or decrease in the apical or
asal compartments were also tested for by one-way ANOVA (after
og transformation). Differences between the uptake of propra-
olol at different pHs, and similarly the efﬂux, were tested for
y ANOVA and statistical signiﬁcance was accepted when P < 0.05
SPSS software, SPSS Inc.). The propranolol ﬂux for each concen-
ration in the concentration–response evaluation was  calculated
t 6 h and analyzed by ordinary least squares linear regression
o describe the best ﬁt, and further analysis of low concentra-
ions was done by cubic polynomial regression to best describe
he relationship (SPSS software, SPSS Inc.). Statistical differences
etween inhibitor (applied either apically or basally) and the
nhibitor-free control were tested for by one-way ANOVA (after
og transformation) and the statistical signiﬁcance was set to
 < 0.05.
.11. Comparison to predicted and actual plasma concentrations
In vitro propranolol ‘internal’ concentrations after uptake (A:B)
rom the concentration–response study were compared to pre-
icted in silico and actual in vivo plasma concentrations of
ropranolol in Oncorhynchus mykiss.  The predicted partition of
ropranolol between blood and water can be determined by
plasma] = 0.87 [water] as described by Owen et al. (2009). This
as calculated using the mammalian ﬁsh leverage model, whereby
he predicted plasma concentration can be described by multi-
lying the environmental concentration by the blood to water
artitioning coefﬁcient (Huggett et al., 2004) using the Fitzsim-
ons model for the partitioning of compounds between blood and
ater (Fitzsimmons et al., 2001). Actual plasma concentrations of
ropranolol in O. mykiss were obtained from Owen et al. (2009).
n vitro propranolol concentrations at 6 h (n = 3–6 from 3 biolog-
cal replicates) were tested for correlation to in silico and in vivo
lasma concentrations by ordinary least squares linear regression
SPSS software, SPSS Inc.)derived from four biological replicates. 14C-mannitol was applied to the apical com-
partment in freshwater, with L-15 medium in the basal compartment. Each data
point represents one DSI epithelium (n = 37) from four biological replicates.
3. Results
3.1. Epithelium membrane characteristics
DSI epithelial development was  monitored through daily mea-
surements of TER in symmetrical conditions, which after 8 days
reached 18.1 ± 1.3 k cm2 (n = 24). After apical freshwater appli-
cation TEP became increasingly negative from −0.9 ± 0.15 mV
to −12.9 ± 2.9 mV  (n = 8). The permeability of the paracellu-
lar marker 14C-mannitol produces a measure of the rate of
paracellular transport for compounds with similar molecular
weights via this route. Mannitol ﬂux in cell free inserts with
a TER of 0  cm2 (blanked) was  3.6 ± 0.2 × 10−6 cm s−1 (n = 4,
Fig. 1). DSI gill epithelia with TER of 200–1000  cm2 exhib-
ited a mannitol permeability of 1.1 ± 1.1 × 10−6 cm s−1, whilst
those >2 k cm2 showed the lowest mannitol permeability of
0.1 ± 0.01 × 10−6 cm s−1, with little variation between epithelia
(Fig. 1).
3.2. Apparent permeability coefﬁcients and transport ratios
In symmetrical conditions with L-15 medium on both sides of
the gill cell epithelium no signiﬁcant differences between Papp A:B
and Papp B:A for all 7 pharmaceuticals was observed (Fig. 2A), yet
all permeabilities were higher than that of the paracellular marker
mannitol (except for atenolol; Papp A:B: 0.1 ± 0.03 × 10−6 cm s−1
and Papp B:A: 0.1 ± 0.02 × 10−6 cm s−1 compared to mannitol;
Papp A:B: 0.1 ± 0.01 × 10−6 cm s−1). In asymmetrical conditions
with freshwater at the apical surface of the gill epithelium,
Papp A:B was signiﬁcantly higher than Papp B:A (P < 0.001) for
propranolol and imipramine, whilst no signiﬁcant differences
existed between uptake and efﬂux Papp of the remaining ﬁve
drugs metoprolol, atenolol, formoterol, terbutaline and ranitidine
(Fig. 2B). For propranolol, the Papp A:B increased signiﬁcantly from
1.7 ± 0.2 × 10−6 cm s−1 in symmetrical to 2.7 ± 0.2 × 10−6 cm s−1 in
asymmetrical conditions (P < 0.05) and Papp B:A decreased signiﬁ-
cantly from 1.1 ± 0.02 to 0.8 ± 0.1 × 10−6 cm s−1 (P < 0.05) (Fig. 2A
and B). Similarly for imipramine a signiﬁcant increase in Papp
A:B from symmetrical (1.9 ± 0.2 × 10−6 cm s−1) to asymmetrical
(3.0 ± 0.1 × 10−6 cm s−1; P < 0.05) and a signiﬁcant decrease in Papp
L.C. Stott et al. / Aquatic Toxicol
Table  2
The uptake and efﬂux transport ratios (TR) of seven drugs in symmetrical and asym-
metrical conditions.
Uptake TR Efﬂux TR
Symmetrical Asymmetrical Symmetrical Asymmetrical
Propranolol 1.52* 3.21* 0.66 0.31
Metoprolol 0.56 1.32 1.78* 0.76
Atenolol 0.74 0.60 1.34 1.67*
Formoterol 1.08 0.97 0.93 1.03
Terbutaline 0.92 0.89 1.09 1.13
Ranitidine 1.21 0.88 0.83 1.14
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aImipramine 0.84 1.83* 1.19 0.55
* represents TR ≥ 1.5.
:A (2.2 ± 0.04 to 1.6 ± 0.1 × 10−6 cm s−1; P < 0.05) (Fig. 2A and B)
as observed.
Propranolol showed uptake TR values greater than 1.5
n both symmetrical and asymmetrical conditions, whilst for
mipramine; this was only observed in asymmetrical conditions.
oth metoprolol and atenolol had efﬂux TR values greater than
.5 in symmetrical and asymmetrical conditions, respectively
Table 2).
.3. Bidirectional transport assays
In symmetrical conditions with L-15 medium on both sides
f the epithelium, ranitidine and imipramine exhibited greater
fﬂux transport from the basal to the apical compartments at 24 h
P < 0.05) and at 30 and 48 h (P < 0.05) respectively. In asymmetri-
al conditions involving the application of freshwater at the apical
urface, more propranolol, ranitidine and imipramine were taken
p across the gill cell surface than efﬂuxed after 48 h. This was sig-
iﬁcantly more so at 6 h (P < 0.001) and 24, 30 and 48 h (P < 0.01)
or propranolol, 30 h (P < 0.01) for ranitidine and at all sampling
0 
1 
2 
3 
Propranolol Metoprolol Atenolol Formoterol  Terbutaline Ranitidine Imipramine 
P a
p
p
 (
1
 x
 1
0
-6
 c
m
 s
-1
) 
0 
1 
2 
3 
Propranolol Metoprolol Atenolol Formoterol Terbutaline Ranitidine Imipramine 
P a
p
p
 (
1
 x
 1
0
-6
 c
m
 s
-1
) 
***
#
A: Symmetrical
Papp A:B 
Papp B:A
#
***#
#
B: Asymmetrical
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ell epithelium at 6 h in symmetrical conditions (A) and asymmetrical conditions (B).
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points (6, 24, 30 and 48 h) for imipramine (P < 0.001). Metopro-
lol, formoterol and terbutaline showed slightly greater uptake than
efﬂux after 48 h, and this was signiﬁcantly more so for formoterol
at 48 h (P < 0.05).
3.4. Concentration-equilibrated transport assays
In symmetrical conditions with L-15 media and test drug on
both sides of the epithelium no signiﬁcant differences between
percentage of the initial drug concentrations in the apical and
basal compartments were observed for metoprolol, terbutaline
and ranitidine at any time point (Fig. 3B). The percentage of the
initial concentration of formoterol was more in the apical than
basal but only signiﬁcantly so at 24 h (P < 0.05). The percentage
of the initial concentration of propranolol in the apical compart-
ment was  signiﬁcantly more than the basal at all sampling points
after 0 h (6 and 24 h P < 0.01 and 30 and 48 h P < 0.05). This was
also seen for imipramine, which showed the same increased basal
to apical facilitated transport (P < 0.001 at 6, 24 and 30 h and
P < 0.01 at 48 h). However, in asymmetrical conditions the situ-
ation was  reversed whereby increased apical to basal transport,
indicative of facilitated uptake, resulted in signiﬁcantly more pro-
pranolol and imipramine in the basal compartments (P < 0.01 at
24 h and P < 0.001 to 30 and 48 h for propranolol and P < 0.01
at 6, 24 and 30 h and P < 0.001 at 48 h for imipramine). The
same was  true for ranitidine in asymmetrical conditions but to
a lesser degree (P < 0.05 at 24, 30 and 48 h). Metoprolol, for-
moterol and terbutaline showed no signs of facilitated transport
across the epithelium as no signiﬁcant differences were observed
(Fig. 3B).
3.5. The pH-dependent transport of propranolol
A decrease in pH from 8 to 6 resulted in a signiﬁcant reduc-
tion in the uptake permeability (Papp A:B) of propranolol from
2.7 ± 0.2 × 10−6 to 0.4 ± 0.03 × 10−6 cm s−1 (P < 0.001) in asymmet-
rical conditions. The effect was  opposite for efﬂux permeability
(Papp B:A) with an increase from 0.8 ± 0.1 to 2.8 ± 0.1 × 10−6 cm s−1
(P < 0.001; Fig. 4). An increase in pH from 8 to 9.5 was without
signiﬁcant effect (Fig. 4).
3.6. The concentration-dependent uptake of propranolol
A positive linear correlation between concentration
(0.014–10,000 g L−1) and ﬂux of propranolol was  observed
with regression line representing the best ﬁt of [rate] = 0.052
[concentration] (n = 54, r2 = 0.974, Fig. 5A). However, at lower
propranolol concentrations (0.014–0.14 g L−1) a 2nd order poly-
nomial regression best described the concentration–response
relationship (n = 24, r2 = 0.927, Fig. 5B) rather than linear (n = 24,
r2 = 0.908) with line representing the best ﬁt of [rate] = 0.057
[concentration].
3.7. The inhibition of the uptake of propranolol
Amantadine and verapamil did not inhibit Papp A:B of propranolol
(Fig. 6A and F). Apical and basal cimetidine application signiﬁcantly
inhibited the transport of propranolol at all time points (apart
from basal at time 6 h) by approximately 40–61.4% ± 3.4 (apical
application) and 55.9% ± 1.3 (basal application) at 48 h (P < 0.001)
(Fig. 6B). Similarly, cyclosporine A showed a signiﬁcant inhibition
of propranolol transport after 48 h to 69.9% (±3.7) of that in the con-
trol (P < 0.01) for apical application andto 66.3% (±6.1) (P < 0.001)
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Fig. 3. The transport assays of six pharmaceuticals: propranolol, metoprolol, formoterol, terbutaline, ranitidine and imipramine, in the DSI rainbow trout primary gill cell
system over 48 h under (A) bidirectional transport assays (BTA) and (B) concentration equilibrium transport assays (CETA) conditions. For BTA (A) the drug is applied at a
concentration of 1 g L−1 to either the apical (–––) for apical to basal transport; uptake, A:B or basal compartment (– – –) for basal to apical transport; efﬂux, B:A in either
symmetrical (L-15 medium in both compartments) or asymmetrical (freshwater in the apical compartment and L-15 medium in the basal) conditions. For this assay, data
are  shown as a percentage of the initial drug concentration in the donor chamber versus time. For CETA (B), the drug is added to both the apical and basal compartments
at  the same concentration (1 g L−1) in both symmetrical and asymmetrical conditions. Data are shown as a percentage of the initial concentration in either the apical or
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aasal  versus time. For both assays, signiﬁcant differences between the two  compar
xperiments were performed in triplicate or more (n = 3–6) from at least one biolog
or basal one (Fig. 6C). Application of the inhibitors MK571 and
uinidine again caused a signiﬁcant decrease in propranolol per-
eability over time by approximately 40% compared to the control
t 48 h for both apical and basal applications (P < 0.001) (Fig. 6D
nd E).s are indicated by asterisk (one-way ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001). All
plicate and values are shown as means ± SEM.
3.8. Comparison to predicted and actual propranolol plasma
concentrations
Predicted plasma concentrations were calculated using
[plasma] = 0.87 [water] and actual plasma concentrations from
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Table  3
Propranolol concentration in silico (predicted), in vivo and in vitro (measured at various external propranolol concentrations).
Nominal propranolol concentration in water (g L−1) In silico (ng mL−1) (Huggett et al., 2004) In vivo (ng mL−1) (Owen et al., 2009) In vitro (ng mL−1)
0.1 0.087 n/a 0.04 (±0.002)
1.0 0.87 0.94* (n/a) 0.10 (±0.001)
10  8.7 3.3 (±0.4) 0.72 (±0.02)
100  87 16 (±7) 7.5 (±0.3)
1000 870 280 (±116) 79.5 (±7.3)
10,000 8700 5200 (±1333) 812 (±158)
100,000 87,000 
* Pooled plasma sample.
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wen et al. (2009) (Table 3). A linear correlation between pre-
icted plasma concentration and in vitro basal concentrations was
btained and described by [in vitro] = 0.063 [predicted] (n = 21,
2 = 0.995, Fig. 7). Furthermore, a correlation between actual
lasma concentrations (Owen et al., 2009) and in vitro basal
oncentrations was obtained and described by [in vitro] = 0.155
actual] (n = 21, r2 = 0.966, Fig. 7).
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4. Discussion
The development of suitable in vitro cellular models to replace,
reﬁne and reduce (3Rs) the numbers of ﬁsh used in ecotoxicological
studies is an important requirement in current regulatory testing
(Scholz et al., 2013). Pharmaceuticals in the environment are con-
taminants of emerging concern and their behavior in water affects
uptake into biological systems (Boxall et al., 2012). Log Kow is often
used to determine the bioconcentration potential of a compound
which may  not be relevant to ionizable compounds such as pharma-
ceuticals (Hermens et al., 2013). The pH-corrected log Dow is used
to account for the fraction of ionizable and nonionisable species of a
substance at a given pH, but this accounts for partitioning between
two liquid phases and does not include partitioning across a biolog-
ical membrane. The present study is the ﬁrst to demonstrate how a
primary rainbow trout gill cell culture system can be used to assess
pharmaceutical uptake from water across a biological membrane.
Therefore, this offers a potential alternative to replace whole organ-
ism pharmaceutical uptake studies at differing water chemistries,
such as different pHs, the presence of dissolved organic matter or
real water samples from the ﬁeld.
Once a tight epithelium (>5 k cm2) has formed, the gills
present a barrier for paracellular transport that is relatively imper-
meable to the paracellular permeability marker 14C-mannitol
(Fig. 1). All pharmaceuticals (except atenolol) were transported
across the epithelium in both directions at a rate greater than that of
14C-mannitol, indicating that their transport is via a transcellular or
carrier-mediated process, as all exhibit molecular weights greaterferent drug permeations for propranolol and imipramine where
more is taken up across the epithelium from the water than efﬂuxed
B
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lol (μg L-1) 
sure to (A) 17 propranolol concentrations ranging from 0.014 to 10,000 g L−1 with
wer concentrations that multiple data points are stacked) and (B) low propranolol
entration] (n = 24, r2 = 0.927). The values represent mean ± SEM from ﬁve biological
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Fig. 6. The inhibition of the uptake of 1 g L−1 (4 nM)  propranolol from apical (freshwater) to basal (L-15 medium) using 400 nM of the six inhibitors amantadine (A); cimetidine
(B);  cyclosporine A (C); MK571 (D); quinidine (E) and verapamil (F), applied either apically, AP (–––) or basally, BL (– – –). Data are shown as percentage of the mean control, CTL
(·  · ·· · ·) over time. Signiﬁcant differences between the apically applied inhibitor and the control are indicated by asterisk (one-way ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001).
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rom the basolateral compartment (Table 2; Figs. 2B and 3A). The
ptake of ionizable chemicals such as pharmaceuticals depends on
H and the acid base constant (pKa) (Lahti et al., 2011). Both pro-
ranolol and imipramine are weak bases with pKa values around
.5. Using the Henderson–Hasselbalch equation, 99% of propranolol
nd imipramine exist in their protonated ionized form at pH 7.4 in
ymmetrical conditions, which then falls to only 98% in freshwa-
er at pH 8. Here, at pH 8, more of the natural unionized forms
re lipid-soluble, and thus may  cross the membrane via passive
ranscellular routes explaining the enhanced uptake. However, the
% change in speciation is unlikely to fully account for the differ-
nce in uptake observed (Fig. 2) and other factors are likely to
lay a role. For example, in symmetrical conditions TEP is posi-
ive (1.9 ± 0.2 mV)  and becomes negative after apical freshwater
pplication (−10.3 ± 0.2 mV,  Fletcher et al., 2000; −12.9 ± 2.9 mV,
ata not shown), to a value similar to that observed in vivo (Potts,
984). The change in membrane potential to basolateral negative
enerates an electrical gradient that aids cation partitioning across
he membrane (Fletcher et al., 2000). Alternatively, the TR values
reater than 1.5 in asymmetrical conditions for propranolol and
mipramine in BTA conditions (Table 2) indicate that a proportion
f the transport is via an carrier-mediated process (Schwab et al.,
003). This observation was substantiated by the concentration
quilibrium transport assay (CETA) that eliminates concentration-
ependent passive transport across the gill epithelium allowing
he observation of carrier-mediated processes that drive xenobio-
ic transport. In CETA the difference in partitioning of radioactivity
etween the two compartments is not due to disproportional loss of
ompound adhering to the plastic ware of the apical and basolateral
ompartments, since in cell free blank insert experiments an equal
ercentage of the initial concentration added was absorbed to each
ompartment and an 80% recovery was obtained after 48 h (data
ot shown). Thus, it is possible to conclude that for propranolol
nd imipramine, facilitated transport makes up approximately 10%
f the total transport, and around 5% for ranitidine efﬂux (Fig. 3B).
Uptake rates are important for predicting potential internal con-
entrations and are used to predict effects based on the “read by hash tag (#P < 0.05; ##P < 0.01; ###P < 0.001). All experiments were performed in
8 from six biological replicates for the inhibitor free controls) and values are shown
across” hypothesis and Mode of Action (Rand-Weaver et al., 2013).
Much of the in vivo uptake work used for these predictions expose
ﬁsh to very high water concentrations and extrapolates back to
these lower environmentally relevant values. Propranolol uptake
is concentration-dependent over the whole range of concentra-
tions but in the low, ng L−1 range, uptake deviates from linearity
(0.014–0.14 g L−1, Fig. 5). A similar result was obtained for the
uptake at very low concentrations of iron across zebraﬁsh gills and
was attributable to proton-dependent metal transporters (Bury and
Grosell, 2003). The facilitated transport of propranolol that occurs
in these environmentally relevant concentrations (Kostich et al.,
2014) is of interest because it suggests that the predictive mod-
els for uptake using data derived for higher concentrations may
underestimate uptake.
The uptake of propranolol is pH dependent up to pH 8, after
which further increases do not cause signiﬁcant effects (Fig. 4). This
again could be attributed to the difference in composition of ion-
ized and unionized species at different pHs, with a caveat that a
proportion of transport is likely via a facilitated process. However, it
should be noted that the pH of the apical bulk compartment, and the
microclimate at the boundary layer, were not measured after the
6 h duration of the experiment, and variations in such may  account
for changes in drug uptake. pH-dependent uptake of propranolol
has been observed in other epithelia including retina (Kubo et al.,
2013), Caco-2 cells (Wang et al., 2010) and kidney MDCK cells
(Dudley et al., 2000). In contrast, efﬂux of propranolol is far greater
at pH 6 than uptake (Fig. 4). This may  suggest the export of pro-
pranolol or its metabolite is pH-dependent. Candidates for drug
export are the ABC transporters; however these are not directly
regulated by pH changes (Altenberg et al., 1993; Neuhoff et al.,
2003). The internal pH of the cells is constant against external pH
changes and thus intracellular speciation of the drug is unlikely to
explain potential increase in efﬂux. It is likely that there are other
propranolol parent and/or metabolite exporters present on the
gill.
Propranolol uptake from water was inhibited by cimetidine,
cyclosporine A, MK571 and quinidine. These are inhibitors of a
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Fig. 7. Propranolol concentrations in the basal compartment of the primary gill cell model after 6 h apical exposure to propranolol in asymmetrical conditions plotted against
(A)  predicted (see text) Oncorhynchus mykiss propranolol plasma concentrations (0.1–100,000 g L−1) with regression line representing the ﬁt of [in vitro] = 0.063 [predicted]
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eplicates.
umber solute carrier and ABC transporters. A number of human
LCs implicated in drug transport (SLC15s, SLCOs, SLC22s and
LC47s [Dobson and Kell, 2008; Giacomini et al., 2010]) are homol-
gous to SLCs found in teleost ﬁsh (Verri et al., 2012). Similarly,
TP-binding cassette (ABC) transporters involved in the cellular
fﬂux of toxicants such as ABCBs, ABCCs and ABCG2 (Deeley et al.,
006) are considered highly conserved amongst vertebrates (Dean
nd Annilo, 2005) and have been documented in rainbow trout
ells both in vivo and in vitro (Fischer et al., 2011; Loncˇar et al.,
010) but not fully characterized. Recent microarray studies using
he primary gill cell culture system have indentiﬁed the presence
f transcripts for genes encoding a number of SLCs, ABCs as well
s biotransformation enzymes (Schnell, Bury, Kille and Hogstrand,
npublished data). But, the identiﬁcation of active proteins requires
urther work.
The application of cimetidine and quinidine, which both interact
ith organic cation transporter OCT2 (SLC22A2) (Giacomini et al.,
010; Koepsell, 2013) signiﬁcantly reduce propranolol uptake. Pro-
ranolol transport via OCT2 was observed in renal LLC-PK1 cells
ransiently transfected with hOCT2-V5, more speciﬁcally in the
ctive uptake of its cationic form across the apical membrane
Dudley et al., 2000). Cimetidine is also used as a blocker of cisplatin
ransport by OCT2 in zebraﬁsh lateral line hair cells (Thomas et al.,
013) and the presence of OCT2-like proteins have been suggested
n other teleost ﬁsh gill epithelia (Verri et al., 2012). MK571 is an
nhibitor of the multidrug resistance protein (MRP) efﬂux pumps
Deeley et al., 2006) and signiﬁcantly inhibited propranolol uptake.
he main MRP  expressed in the gill is MRP3 (ABCC3) (Loncˇar et al.,
010). P-glycoprotein (Pgp; ABCB1) is implicated in propranolol
ransport in rabbit conjunctivial epithelial cells (Yang et al., 2000)
nd Caco-2 cells (Wang et al., 2010) and is present in rainbow trout
issues but at low levels in the gill (Loncˇar et al., 2010). Whether
gp is involved in propranolol transport in the gill cell culture sys-
em is unclear. In addition to inhibiting OCT2, quinidine also acts as
gp inhibitor (Giacomini et al., 2010) and cyclosporine A, another
gp inhibitor, also blocked propranolol transport but this may  be
ia MRP  inhibition instead. Application of the Pgp inhibitor vera-
amil, however, did not affect propranolol transport (Fig. 6F). Taken
ogether these observations would suggest that OCT2 and MRP3
ay  be candidates for propranolol transport across the teleost gill
pithelium, but the location (apical or basolateral membrane) of
hese transporters, and others, needs further assessment.
Owen et al. (2009) showed that predicted plasma concentra-
ions (Fitzsimmons et al., 2001) were good indicators of propranolol
ptake over a range of high concentrations. Our data also correlatesmed in triplicate or more (n = 3–5) and represent mean ± SEM from three biological
well with predicted (Fig. 7A) and measured plasma concentrations
(Fig. 7B). However, in vitro propranolol concentrations in the baso-
lateral compartment were an average 6% of the predicted and 16% of
actual plasma concentrations, whilst actual plasma concentrations
were only 59% of predicted (Owen et al., 2009). In vivo bioconcen-
tration studies can involve an uptake phase of 60 days until a steady
state is reached (OECD305; OECD, 2012). Owen et al. (2009) used a
40-day exposure period, and both procedures use a ﬂow through
system with a steady-state endpoint. Our in vitro assay took place
over 6 h in a static system, which could account for reduced propra-
nolol uptake. Furthermore, actual plasma concentrations may  be
lower than predicted as a proportion of the drug may  bind to pro-
teins or be metabolized by the gill (as suggested by Bartram et al.,
2011), which prediction models fail to take into account. Neverthe-
less, the relationships between this in vitro system to predicted and
actual propranolol plasma concentrations suggest its applicability
as a suitable in vitro model to investigate the uptake of xenobi-
otics and when combined with elimination rates, may supplement
in vivo bioconcentration ﬁsh studies. These model pharmaceuticals
used do not bioaccumulate; however, they may  be taken into a
ﬁsh, and or excreted. This functional primary gill model facilitates
our better understanding of these processes. Currently legislation
requires assessment for compounds of log Kow higher than 3. This
is an arbitrary value and we suspect that this value may  be con-
servative with little prospect of signiﬁcant bioaccumulation for
compounds lower than log Kow 4. This model provides a rapid
and ethically acceptable tool with which to perform a preliminary
assessment of compounds of low log Kow, and as such ideal for large
numbers of pharmaceuticals that typically have a lower propensity
to bioaccumulate.
The study shows that as well as the passive uptake and efﬂux
of neutral forms of pharmaceuticals, water enhances drug uptake
of ionizable pharmaceuticals via both passive transcellular and car-
rier mediated processes. Hence, the ability of this system to tolerate
freshwater is fundamental if we are to simulate in vivo drug uptake
across the gill. In addition, the facilitated uptake of propranolol
was more evident at low concentrations that are more environ-
mentally relevant; suggesting that in certain situations uptake may
be under predicted. Indeed there is signiﬁcant variation (ﬁve-fold)
recorded in plasma concentrations of individual ﬁsh exposed to
pharmaceuticals in vivo (Owen et al., 2009), and it could be that
individual difference in transporter expression may be a mechanis-
tic explanation for this variance. The use of this system provides an
opportunity to reduce the numbers of ﬁsh used in regulatory eco-
toxicological testing as the primary gill cells cultured from two  ﬁsh
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ay  provide up to 72 individual gill cell cultures, and this method
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